Substance Use Disorders

The FDA has given clearance to an investigational new drug application for TMP-301, a treatment for cocaine use disorders, according to the drug manufacturer.

The Substance Abuse and Mental Health Services Administration announced the results of its annual national survey on drug use and health for 2021.

The rate of cocaine use during pregnancy increased in a Northern California health system compared with population-level increases in the United States from 2011 to 2019, according to a study in JAMA Network Open.

Researchers found positive associations between depressive features and self-stigma for those with substance use disorders, with the pull to self-stigma likely stronger than in the reverse, per a study published in BMC Psychiatry.

We compiled a list of stories involving substance use and children that were published in 2022.

Deaths involving fentanyl in people aged 10 to 19 years increased by 182% from 2019 to 2021, among other findings reported in a study published in MMWR.

For those with substance use disorders, COVID-19 is a significant risk factor for endocarditis, researchers reported in Molecular Psychiatry.

HHS has proposed changes to a regulation that protects patient privacy and records concerning treatment related to substance use challenges from unauthorized disclosures. According to a release from HHS, the move was made through the Office for Civil Rights and SAMHSA.

Medicare beneficiaries have less geographic accessibility to substance use disorder treatment facilities, as Medicare acceptance is lower compared with other kinds of payment, per a study published in JAMA Network Open.

A behavioral change digital health company has announced positive results from a randomized controlled trial for its app-based digital tool for tobacco use cessation.